Merck (NYSE:MRK) announced a major reorganization of its Human Health business into two global units focused on Oncology and ...

Ahead of the looming loss of Keytruda’s exclusivity, the company is creating a standalone, cancer-focused unit and a second business housing its other drugs and vaccines.

Merck Foundation (Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany in partnership with African First Ladies announced the winners of Merck Foundation “Mask up with Care” Media ...

Merck, known as MSD outside the U.S. and Canada, is restructuring its Human Health organization and appointing three new leaders.

The patent cliff for Keytruda is fast approaching in the U.S. Now, as Merck & Co. increasingly looks to life after its oncology megablockbuster, the company is honing its focus on new and upcoming ...

Dr. Rasha Kelej, CEO of Merck Foundation, has been recognized among the "100 Most Impactful Voices 2026" by ABCD Africa, a prestigious recognition celebrating influential women of African descent who ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM ESTCompany ParticipantsCaroline Litchfield - Executive ...

Rasha Kelej, CEO of Merck Foundation and President, Merck More Than a Mother has been featured in the list of 100 Most Influential African Women 2020, released by ‘Be a Girl’ Initiative, for the ...

Thousands of jobs could be on the horizon for American workers as drug manufacturer Merck takes steps to move manufacturing into the U.S., particularly in the form of a $1 billion state-of-the-art ...

Merck reported breakthrough pivotal Phase 3 results for Keytruda-based combinations in renal cell carcinoma and ovarian cancer. The company also announced positive clinical trial data for a new HIV ...

21 Winners of Merck Foundation More Than a Mother Fashion Awards 2020 from Ghana, Namibia and Zambia were celebrated during the ceremony; 2 New fashion awards 2021 were announced by Merck Foundation ...